Day 1
You bring a mandate
Your target return, risk and drawdown limits, markets you can trade, and anything already in your book. We agree the pass/fail bar before any testing starts.
For funds and traders with a mandate
Bring me your mandate: target return, risk limits, markets. In one week, for a fixed fee, I build and test strategies against it with strict anti-overfitting checks, and tell you plainly what holds up and what does not.
1 · The one-week trial
Fixed fee, fixed scope, one week. You decide afterwards whether to continue.
Day 1
Your target return, risk and drawdown limits, markets you can trade, and anything already in your book. We agree the pass/fail bar before any testing starts.
Days 2–6
I research and test my own strategy hypotheses for your brief. Rules are written down and locked before results are seen, and every candidate goes through strict anti-overfitting checks.
Day 7
A short report with a clear verdict (pass, pass with caveats, or fail) for each strategy, the key numbers set against your mandate, honest caveats, and a recommended next step.
2 · Case studies
Case studies against published fund mandates, not past clients. Each one takes a brief that a fund or platform has made public, builds a strategy for it in about a week, and tests it the same way as the strategy log: rules locked in advance, data after 30 Sep 2025 kept for testing only, double trading costs and one-day-late trades.
Results are backtests, not live track records. Each card links to a one-page PDF.
Public pension · crisis-risk offset
Verdict: pass
The brief. A US state pension keeps 20% of its plan in a crisis-risk-offset portfolio. The risk-premia part must have little stock-market exposure, hold up in crashes like early 2020 and 2022, and beat T-bills + 2% after costs.
One-week approach. A seasonal commodity strategy that earns returns unrelated to stocks, plus a rules-based switch into bonds and gold when stocks weaken, and a small slow-trend slice.
Key results. Stock-market sensitivity −0.02 (target under 0.2). Up in Q1 2020 (+0.2%) and 2022 (+4.2%). Beat cash in 19 of 19 years, about 7.6% a year, worst fall −4.9%. Beat T-bills + 2% by 4.0% a year before Oct 2025 and by 0.7% in the test year.
Honest caveats. Measured above cash, the test-year Sharpe is a modest 0.79 (0.68 with double costs and late trades). After adjusting for the many ideas we have tested, the evidence is moderate, not conclusive. The seasonal part trades rarely.
Download PDFFirst-loss seeder · tight drawdown
Verdict: pass with caveats
The brief. A seeder that levers a manager's capital (up to 10×) wants small, steady losses: a hard stop at −8.5%, a target worst fall of 3–5% including the COVID crash, a strong Sharpe (we used 1.5) and money made every year.
One-week approach. The same risk-premia sleeve, run at very low risk with day-to-day volatility steering.
Key results. Worst fall −3.1% across the period, including 2008 and early 2020. A random-reshuffle stress test puts a bad-case fall at −6.1%. At 2× leverage the worst fall from a peak is −8.1%, but never more than −4.0% below a year's starting value, so the −8.5% hard stop is never hit. Beat cash in 19 of 19 years.
Honest caveats. Sharpe is 1.56, or 1.23 measured above cash, under the 1.5 target. A bad year could still break a 5% loss limit. The evidence adjusted for the number of ideas tested is moderate.
Download PDFMulti-manager crypto fund · market neutral
Verdict: promising, not client-ready
The brief. A multi-manager crypto fund wants market-neutral pods targeting about 20% a year net, a Sharpe above 1.5 (less if truly different from what they hold), and little exposure to the crypto market.
One-week approach. A weekly trade across the most-traded coins: buy the coins where futures traders are least crowded into long bets, sell the most crowded, balanced so a bitcoin move hits both sides equally.
Key results. Test period (Oct 2025 – Nov 2026): 20.3% a year, Sharpe 1.33, worst drop −11%, while bitcoin fell 30%. Almost no link to bitcoin (correlation −0.16).
Honest caveats. Sharpe is below the 1.5 bar. Its worst drop in 2021–22 was −33%. After adjusting for the many ideas tested, we can't rule out luck. Weekly trading is slower than this client prefers. We recommend 3 months of paper trading first.
Download PDFCrowd-sourced prediction tournament
Verdict: originality not proven
The brief. A crypto prediction tournament wants a daily ranking of about 300 coins, scored on how well it matches each coin's return over the next ~30 days. It pays most for signals that add something new.
One-week approach. A simple rule-based score with no machine learning: coins that are uncrowded in futures markets and have had calm prices rank high.
Key results. Ranking match with future returns of 0.115 in the test period (typical tournament signals score about 0.01–0.03).
Honest caveats. Almost all the strength comes from the well-known “calm coins beat jumpy coins” pattern (0.139 on its own in the test period), so it may add little that is new. The crowding part alone is weak. We tested about 74 coins, not 300, during a falling market. Next step: submit live, unstaked, for 8–12 rounds.
Download PDFTrader-seeding programme
Verdict: pass on the test year, with caveats
The brief. To reach GOLD, a strategy needs 8+ months of live history on the platform and, for example, a 1-year return above 20% with return divided by worst fall above 2.5. The platform runs it at a fixed risk level.
One-week approach. The risk-premia sleeve scaled up to the platform's fixed risk level.
Key results. Test year (Oct 2025 – Oct 2026): +24.6% with a worst fall of −5.9% (ratio 4.2). With double costs and late trades: +23.0% (ratio 3.5).
Honest caveats. Leverage: this needs up to about 3× leverage. Capped at 2×, the test-year return falls to +16.3%, below the 20% bar. Consistency: it would have qualified in only 6 of 10 past years, so any given year is likely but not assured. It also needs futures access on the platform and 8+ months of live history there.
Download PDF3 · Why trust the research
Most backtests flatter. Every strategy I hand over has to survive four checks first.
The most recent stretch of data is set aside and never used to pick or tune anything. It is used once, as a final exam.
If you try enough ideas, some look great by chance. The results are adjusted for how many ideas were tried overall.
The returns are randomly reshuffled many times to check the result is not a fluke of one lucky sequence, and how bad a bad run could get.
Every trade is filled a bar late and trading costs are doubled. A strategy that only works with perfect timing or free trading is dropped.
4 · Background
1 · Research framework
Nine steps from hypothesis to conditional live deployment. Tap a step for detail.
Ideas originate from newsletters, books, academic and industry research, exploratory data analysis, and TQG-assisted idea generation.
Define data source, universe, sample period, information availability, and a frozen out-of-sample split before testing. Search stays before the study-specific cut (often 2025-01-01).
Implement and backtest with safeguards aimed at mitigating lookahead and survivorship bias; their effectiveness is validated rather than assumed perfect.
Seek a stable high-Sharpe plateau, not a single best point; choose a representative/median configuration or an ensemble using development data only.
Fees, slippage, and a 2× cost stress on OOS. When a trial matrix exists: DSR, PBO / CSCV, shift nulls, and beat-random-search checks.
Publish qualifying research tracks and archive rejected or no-edge hypotheses with transparent decisions. Every hypothesis receives a verdict.
Monte Carlo simulations and stress scenarios estimate plausible variability, drawdown ranges, and failure conditions for candidate systems.
Paper trade and monitor operational behavior, realized signal generation, and divergence from research assumptions before any capital commitment.
A conditional future stage under explicit capital, operational, and risk controls. This site does not imply live trading where it has not occurred.
2 · Strategy log
Strategies still standing after out-of-sample, cost, delay and multiple-testing checks. Sharpe for the flagship is shown above cash. Click a row for details and the equity curve.
What we threw away: 7 previously listed strategies were removed after failing these checks (6 failed a corrected re-test, 1 did not survive realistic execution); 3 others came back as candidates after that re-test. Across 1,901 strategy variants tested so far, none has yet cleared the strictest multiple-testing bar, so everything here is labelled as still in testing.
| Strategy ID | Strategy | Class | Sharpe (over cash) | Max DD | CAGR |
|---|
Next
Send your mandate, or a short description of what you are looking for, and I will reply with scope and the fixed fee for a one-week trial. Also open to fractional research engagements and collaborations.